BioUtah president & CEO Kelvyn Cullimore interviews Mayer Brown’s George O’Brien to discuss legal issues life sciences companies face when dealing with the FDA.
Stay Up To Date With Our Insights
See how we use a multidisciplinary, integrated approach to meet our clients' needs.
Subscribe